--- title: "The 'Others' Bucket of Wall Street: Who's Faking It and Who's Actually Making Money" type: "News" locale: "en" url: "https://longbridge.com/en/news/294798168.md" description: "The miscellaneous bucket of US stocks is a chaotic mix of 2026's biggest trends and fading legacies. From Amazon-backed electric aviation to struggling retailers, here is a sharp look at 10 random tickers and why they matter." datetime: "2026-08-04T09:31:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294798168.md) - [en](https://longbridge.com/en/news/294798168.md) - [zh-HK](https://longbridge.com/zh-HK/news/294798168.md) generator: "portal-rs" --- # The 'Others' Bucket of Wall Street: Who's Faking It and Who's Actually Making Money Let's be completely honest: the "Others" bucket on Wall Street is basically the junk drawer where analysts throw everything they can't neatly categorize. But if you dig into this chaotic mix, it's actually a perfect microcosm of everything absurd and real in the 2026 market. From the overhyped electric aviation sector to desperate biotech bets and legacy retail pretending it's not dying, this group is a hot mess. This is stupid and here's why: you can't just ignore these tickers because they lack a shiny AI label, but we also shouldn't pretend half of them aren't zombies walking. Let's start with the adults in the room. Analog Devices (ADI.US) is quietly minting money while everyone else screams about Nvidia. The semiconductor heavyweight just dropped **USD 3.62 billion** in Q2 2026 revenue, beating expectations across the board, and its valuation is comfortably sitting among the most valuable chipmakers after a solid year-to-date run. Why aren't you moving faster? Because they don't need to. They make the industrial and communication chips that actually run the world, generating **USD 5.1 billion** in operating cash flow. No flashy keynotes, just cold, hard cash. Speaking of actual businesses, Kulicke & Soffa (KLIC.US) is riding the semiconductor assembly wave. Driven by a rebound in memory and advanced packaging, the company's Q2 2026 revenue surged roughly **50%** year-over-year to **USD 242 million**. The stock has been bouncing back nicely this year. Wall Street has the memory of a goldfish, but as long as the world needs chips packaged, this mid-cap equipment maker is going to get paid. On the flip side, Kohl's (KSS.US) is acting like a living fossil from the 1990s. The department store saw its comparable sales slide another **1.1%** in Q1 2026. Sure, management patted themselves on the back for cleaner inventory, and the stock even saw a brief dead-cat bounce, but a department store with a shrinking valuation in the age of rapid e-commerce? Good luck with that. If you want pure speculation, BETA Technologies (BETA.US) is your ticket. This electric aviation (eVTOL) player went public in late 2025 and is already burning through **USD 91.7 million** in R&D in a single quarter. But because Amazon took a **5.3%** stake, the stock has soared recently, pushing its valuation to new heights. Jeff is clearly betting on the future of drone logistics, but BETA still needs to prove its cash burn won't outpace its actual flight speed. Then we have the micro-cap bottom feeders. Over at Beyond Air (XAIR.US), CEO Robert just threw roughly **USD 200,000** of his own money into company shares this July to prop up a sliding stock. The company doubled its FY2026 revenue to **USD 7.7 million** with its nitric oxide therapies, but that's a rounding error when you're trying to convince the market you can revolutionize lung disease treatment. Medical tech firm Adagio Medical (ADGM.US) is selling another distant dream. They just treated their first patient with their next-gen vCLAS Ultra ablation system in August. Sounds incredibly cool, until you see their **USD 25.1 million** net loss for FY2025 and a stock chart that looks like a flatline. The commercialization marathon is just starting, and they are already out of breath. Calidi Biotherapeutics (CLDI.US) is in the same leaky boat. The oncolytic virotherapy company just executed a desperate 1-for-16 reverse stock split in July to stay listed. With a Q1 2026 net loss of **USD 4.4 million**, the firm has collapsed into micro-cap territory. This is the ultimate biotech roulette. The house usually wins, and Calidi's chips are running perilously low. The Chinese ADRs in this group aren't doing much better. Jinxin Technology (NAMI.US) barely managed to regain Nasdaq compliance this July. They are pushing a new AI learning companion, projecting **USD 70 million** in FY2025 revenue, but the ed-tech hardware space is brutal. Meanwhile, Taoping (TAOP.US) is hustling smart city screens and elevator displays. They scored a **USD 5.2 million** order in July, but FY2025 revenue dropped 16% to **USD 30.8 million** alongside a massive net loss. Wake up, the smart elevator narrative isn't fooling anyone anymore. Finally, we have the Vanguard Core Bond ETF (VCRB.US). In a basket filled with cash-burning air taxis and penny-stock biotechs, this massive bond ETF—chugging along with a reliable dividend yield—is the only thing that lets you sleep at night. When the market gets this absurd, sometimes boring fixed income is the smartest play in the room. My view is clear: apart from massive cash-generators like ADI and billionaire-backed lotto tickets like BETA, the rest of this "Others" list deserves to stay exactly where Wall Street left it—in the junk drawer. *This article does not constitute investment advice.* ### Related Stocks - [XAIR.US](https://longbridge.com/en/quote/XAIR.US.md) - [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md) - [NAMI.US](https://longbridge.com/en/quote/NAMI.US.md) - [KSS.US](https://longbridge.com/en/quote/KSS.US.md) - [BETA.US](https://longbridge.com/en/quote/BETA.US.md) - [CLDI.US](https://longbridge.com/en/quote/CLDI.US.md) - [TAOP.US](https://longbridge.com/en/quote/TAOP.US.md) - [KLIC.US](https://longbridge.com/en/quote/KLIC.US.md) - [ADI.US](https://longbridge.com/en/quote/ADI.US.md) ## Related News & Research - [These Analysts Revise Their Forecasts On Analog Devices After Q3 Earnings](https://longbridge.com/en/news/296515974.md) - [Emerald Investment Advisers LLC Purchases Shares of 18,058 Analog Devices, Inc. $ADI](https://longbridge.com/en/news/296677264.md) - [German American Bancorp Inc. Purchases Shares of 8,240 Analog Devices, Inc. $ADI](https://longbridge.com/en/news/296074334.md) - [Analog Devices Sees 100 GW Data Center Buildout By 2031, Worth $1B-$1.5B Per GW](https://longbridge.com/en/news/296514607.md) - [Analog Devices Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/296218304.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**